We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

How Leukemia Viruses Spread from Cell to Cell

By Biotechdaily staff writers
Posted on 26 Feb 2003
Researchers have learned how human T-lymphotropic virus type 1 (HTLV-I), which causes adult T-cell leukemia, spreads from cell to cell within the body without the release of infectious virus particles. Their findings were published February 13, 2003, in the online edition of Science.

It was known that cell contact was required for efficient transmission of HTLV-I between cells and between individuals, because naturally infected lymphocytes produce virtually no cell-free infectious HTLV-I particles. However, the mechanism of this transmission was not well understood.

In the current study, investigators from Imperial College (London, UK; www.imperial.ac.uk) and their colleagues found that cell contact rapidly induced polarization of the cytoskeleton of the infected cell to the cell-cell junction. HTLV-I core (Gag protein) complexes and the HTLV-I genome accumulated at the cell-cell junction and were then transferred to the uninfected cell.

Senior author Professor Charles Bangham from the department of immunology of Imperial College explained, "The HTLV-1 virus affects between 10 and 20 million people worldwide with around 2-3% developing leukemia. Although this research is not a cure, it does show how the virus is able to spread through the body and infect other people. From this we hope to be able to develop more effective treatments for this fatal disease.”

Professor Bangham went on to say, "HTLV-1 is a very similar virus to HIV. It is spread through the same methods, and if we can use this research to develop a way of treating HTLV-1, this research could be a crucial first step towards developing new and more-effective treatments to combat the global AIDS epidemic.”



Related Links:
Imperial College

New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Thyroid Test
Anti-Thyroid EIA Test
New
Multi-Chamber Washer-Disinfector
WD 390

Latest BioResearch News

Study Identifies Protein Changes Driving Immunotherapy Resistance in Multiple Myeloma
26 Feb 2003  |   BioResearch

Genetic Analysis Identifies BRCA-Linked Risks Across Multiple Cancers
26 Feb 2003  |   BioResearch

Study Identifies Hidden B-Cell Mutations in Autoimmune Disease
26 Feb 2003  |   BioResearch